<DOC>
	<DOCNO>NCT01837355</DOCNO>
	<brief_summary>Pulmonary inflammation independent risk factor disease progression cystic fibrosis patient ( CF ) . Yet , effective treatment know reduce detrimental inflammation . Dysbiosis gut microbiota link inflammation several inflammatory disease . As child CF different faecal microbiota healthy sibling , modulate gut microbiota lactobacillus rhamnosus diet supplementation might strategy target inflammatory state CF . Study subject ( CF healthy control ) receive either placebo lactobacillus rhamnosus daily dietary supplementation 12 week . After one-week washout phase , switch another 12 week trial arm . Effect intestinal pulmonary inflammation well clinical outcome study .</brief_summary>
	<brief_title>Modulation Intestinal Pulmonary Inflammation Lactobacillus Diet Supplementation Pediatric Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<criteria>moderate severe CF disease acute gastroenteritis 2 week prior inclusion chronic disease CF ( except CF associate disorder ) oral parenteral antibiotic 2 week prior inclusion systemic steroid 4 week prior inclusion probiotic intake</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>